v3.26.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
General and administrative $ 6,464,371 $ 6,090,747
Research and development 11,514,123 16,125,690
Total operating expenses 17,978,494 22,216,437
Loss from operations (17,978,494) (22,216,437)
Interest income 437,931 742,355
Other income, net 421,125 692,869
NET LOSS $ (17,119,438) $ (20,781,213)
Net loss per share of common shares, basic $ (1.57) $ (1.93)
Net loss per share of common shares, diluted $ (1.57) $ (1.93)
Weighted-average number of common shares outstanding, basic 10,898,175 10,762,319
Weighted-average number of common shares outstanding, diluted 10,898,175 10,762,319